Cryoport, Inc. (CYRX)
16.81
-0.54
(-3.11%)
USD |
NASDAQ |
Oct 08, 15:56
Cryoport Enterprise Value : 760.35M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 760.35M |
| October 06, 2026 | 783.14M |
| October 05, 2026 | 800.36M |
| October 02, 2026 | 764.40M |
| October 01, 2026 | 760.86M |
| September 30, 2026 | 762.88M |
| September 29, 2026 | 758.83M |
| September 28, 2026 | 761.87M |
| September 25, 2026 | 763.39M |
| September 24, 2026 | 762.88M |
| September 23, 2026 | 767.44M |
| September 22, 2026 | 771.49M |
| September 21, 2026 | 774.03M |
| September 18, 2026 | 743.64M |
| September 17, 2026 | 731.48M |
| September 16, 2026 | 717.81M |
| September 15, 2026 | 707.68M |
| September 14, 2026 | 689.95M |
| September 11, 2026 | 669.18M |
| September 10, 2026 | 655.00M |
| September 09, 2026 | 648.42M |
| September 08, 2026 | 665.13M |
| September 04, 2026 | 682.35M |
| September 03, 2026 | 684.89M |
| September 02, 2026 | 680.83M |
| Date | Value |
|---|---|
| September 01, 2026 | 669.18M |
| August 31, 2026 | 691.98M |
| August 28, 2026 | 696.53M |
| August 27, 2026 | 720.85M |
| August 26, 2026 | 720.85M |
| August 25, 2026 | 728.44M |
| August 24, 2026 | 709.20M |
| August 21, 2026 | 749.21M |
| August 20, 2026 | 727.94M |
| August 19, 2026 | 707.68M |
| August 18, 2026 | 645.89M |
| August 17, 2026 | 657.54M |
| August 14, 2026 | 653.99M |
| August 13, 2026 | 647.91M |
| August 12, 2026 | 631.20M |
| August 11, 2026 | 638.80M |
| August 10, 2026 | 632.21M |
| August 07, 2026 | 647.41M |
| August 06, 2026 | 626.64M |
| August 05, 2026 | 653.99M |
| August 04, 2026 | 652.47M |
| August 03, 2026 | 666.15M |
| July 31, 2026 | 645.89M |
| July 30, 2026 | 658.04M |
| July 29, 2026 | 637.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 56.78B |
| Protect Pharmaceutical Corp. | 3.751M |
| Champions Oncology, Inc. | 75.10M |
| Medpace Holdings, Inc. | 16.46B |
| Charles River Laboratories International, Inc. | 17.20B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.255M |
| Revenue (Quarterly) | 48.97M |
| Total Expenses (Quarterly) | 57.23M |
| EPS Diluted (Quarterly) | -0.2033 |
| Gross Profit Margin (Quarterly) | 39.66% |
| Profit Margin (Quarterly) | -16.86% |
| Earnings Yield | -4.86% |
| Normalized Earnings Yield | -4.893 |